Sign In
Buy CTMX
$3.22
+0.0600 (+1.90%)
At Close: Jun 03, 2026
CLASS ACTION UPDATE for PRA, WORX and CTMX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
11:00pm, Wednesday, 24'th Jun 2020
NEW YORK, NY / ACCESSWIRE / June 24, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CTMX, CLNY and WFC
11:20pm, Tuesday, 23'rd Jun 2020
NEW YORK, NY / ACCESSWIRE / June 23, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to particip
LOS ANGELES, CA / ACCESSWIRE / June 23, 2020 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against CytomX Therapeutics, Inc. ("C
CLASS ACTION UPDATE for PRA, HALL and CTMX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
05:40pm, Tuesday, 23'rd Jun 2020
NEW YORK, NY / ACCESSWIRE / June 23, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders
NEW YORK, NY / ACCESSWIRE / June 23, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can rev
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HALL, CONN and CTMX
11:45pm, Monday, 22'nd Jun 2020
NEW YORK, NY / ACCESSWIRE / June 22, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to particip
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of CytomX Therapeutics, Inc. (NASDAQ: CTMX) between May 17, 2018, and May 13, 2020, inclusive (the "Class Period
LOS ANGELES, CA / ACCESSWIRE / June 22, 2020 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against CytomX Therapeutics, Inc. ("C
CLASS ACTION UPDATE for CTMX, ENDP and CEMI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
06:45pm, Monday, 22'nd Jun 2020
NEW YORK, NY / ACCESSWIRE / June 22, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders
NEW YORK, NY / ACCESSWIRE / June 22, 2020 / Pomerantz LLP announces that a class action lawsuit has been filed against CytomX Therapeutics Inc. ("CytomX" or the "Company") (CTMX) and certain of its of
New York, New York--(Newsfile Corp. - June 22, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in CytomX Therapeutics, Inc. (NASDAQ: CTMX) ("CytomX" or the "Com
The electronic poster #4551 titled “Preclinical characterization of novel anti-CTLA-4 prodrug antibodies with an enhanced therapeutic index” was presented as part of the Therapeutic Antibodies 3 S
Two Sigma Investments LP Sells 131,777 Shares of CytomX Therapeutics Inc (NASDAQ:CTMX)
08:02am, Monday, 22'nd Jun 2020
Two Sigma Investments LP lessened its holdings in shares of CytomX Therapeutics Inc (NASDAQ:CTMX) by 42.4% in the first quarter, according to its most recent disclosure with the Securities & Exchange
Lawsuits Filed Against HALL, CTMX and SRNE - Jakubowitz Law Pursues Shareholders Claims
05:20am, Monday, 22'nd Jun 2020
NEW YORK, NY / ACCESSWIRE / June 22, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who
